Login to Your Account



Financings Roundup

IPO Flurry Continues: Receptos Files Proposed $86M Offering

By Jennifer Boggs
Managing Editor

Monday, April 8, 2013
Receptos Inc. became the seventh U.S. biotech to file for an initial public offering (IPO) this year, taking advantage of the emerging growth company provision in the Jumpstart Our Business Start-ups Act and aiming to raise as much as $86.3 million to support clinical work in multiple sclerosis, inflammatory bowel disease (IBD) and allergic/immune-mediate disorders.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription